Kazia Therapeutics Ltd (1075880) SEC Filing 6-K Foreign Issuer report for the period ending Monday, January 7, 2019

Kazia Therapeutics Ltd

CIK: 1075880

View differences made from one to another to evaluate Kazia Therapeutics Ltd's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 6-K Foreign Issuer Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Kazia Therapeutics Ltd.


Assess how Kazia Therapeutics Ltd's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Kazia Therapeutics Ltd's Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
CIK: 1075880
Form Type: 6-K Foreign Issuer Report
Accession Number: 0001193125-19-003036
Submitted to the SEC: Mon Jan 07 2019 6:23:14 AM EST
Accepted by the SEC: Mon Jan 07 2019
Period: Monday, January 7, 2019
Industry: Pharmaceutical Preparations

External Resources:

Bookmark the Permalink: